Simple jQuery Dropdowns
Please use this identifier to cite or link to this item:
Title: Effects of paclitaxel and carboplatin on quality of life and survival in patients with advanced non-small-cell lung cancer
Authors: Vorachai Ratanatharathorn
Ekapob Sirachainan
Manmana Jirajarus
Mahidol University
Keywords: Medicine
Issue Date: 1-Sep-2000
Citation: Journal of the Medical Association of Thailand. Vol.83, No.9 (2000), 1059-1067
Abstract: The purpose of this phase II study was to determine the effects of paclitaxel plus carboplatin administered by short duration on response rate, toxicity, and quality of life (QOL) in patients with non-small cell lung cancer (NSCLC). Twenty-seven patients were enrolled in this study. The objective response rate was 48.2 per cent, grade 3 or 4 granulocytopenia and thrombocytopenia were observed in 22 per cent and 1.6 per cent, respectively. QOL was assessed in nineteen patients who completed six cycles of chemotherapy. Quality of Life Index (QLI) after six cycles of treatment showed no significant change from the baseline QOL. Compliance with the QOL protocol in this study diminished with the course of chemotherapy which is comparable to the literature figure. Thus, withholding current effective chemotherapy in patients with NSCLC with good performance status is no longer justified.
ISSN: 01252208
Appears in Collections:Scopus 1991-2000

Files in This Item:
There are no files associated with this item.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.